- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Vyera Pharmaceuticals, Phoenixus AG Announce Agreement to Sell Daraprim and Vecamyl Rights
Deal comes amid companies’ bankruptcy filings.
Vyera Pharmaceuticals and Phoenixus AG have revealed their entrance into an asset purchase agreement regarding Daraprim and Vecamyl. The agreement comes amid the organizations’ filling for Subchapter V bankruptcy. The aggregate consideration to be paid for the sale and transfer of the purchased assets and the assignment of the certain contracts, subject to adjustment, shall be $650,000 together with the assumption of post-closing liabilities.
According to a company press release, DLA Piper LLP is serving as the Vyera's legal counsel, with SierraConstellation Partners LLC providing financial advice, and Alvarez and Marsal Securities LLC working as investment bankers.
Reference: Vyera Pharmaceuticals, LLC and Phoenixus AG Sign Asset Purchase Agreement to Sell Rights to Daraprim and Vecamyl. PR Newswire. August 1, 2023. Accessed August 3, 2023. https://www.prnewswire.com/news-releases/vyera-pharmaceuticals-llc-and-phoenixus-ag-sign-asset-purchase-agreement-to-sell-rights-to-daraprim-and-vecamyl-301890830.html
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
